| abstract |
The present invention relates to novel glucagon peptides having improved stability and solubility at neutral pH, the use of the compounds in therapy, therapeutic methods and medicaments comprising administering the compounds to patients in need thereof It relates to the use of the compounds in the production. The glucagon peptides of the invention are particularly important for the treatment of various diseases or conditions associated with hyperglycemia, diabetes and obesity, as well as hyperglycemia, diabetes and obesity. |